Market Tracker

10/22 6:06pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

6.21
Data as of Oct 22
 +0.19 / +3.16%
Today’s Change
5.92
Today|||52-Week Range
24.33
-66.07%
Year-to-Date

Today’s Trading

Previous close6.02
Today’s open6.42
Day’s range6.12 - 7.11
Volume2,589,445
Average volume (3 months)1,182,356
Market cap$139.1M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-13.66%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
VTAEVitae Pharmaceutical...+0.36+4.68%
MDWDMediwound Ltd-0.16-2.57%
TRVNTrevena Inc+0.21+4.17%
GLYCGlycoMimetics Inc-0.08-1.15%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts